Advanced Filters
noise

myopia Clinical Trials

A listing of myopia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 110 clinical trials
J Jia Qi Zhou, MD, PhD

Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children

There are two parts to this trial. First, to compare the rate of myopia progression of spectacle films using Spatio Temporal Optic Phase (S.T.O.P.®) technology that provide a dynamic optical cue against single vision spectacle lenses. Second, to compare the rate of myopia progression of spectacle films using S.T.O.P.® technology …

6 - 14 years of age All Phase N/A
H Henry HL Chan, PhD

Pharmacological and Non-pharmacological Treatment Effects on Children With Different Predicted Myopia Progression Rate

The goal of this clinical trial is to compare pharmacological and non-pharmacological treatment effects on the children with different predicted myopia progression rate measured by modified multifocal electroretinogram. The main questions it aims to answer are: the effectiveness of using 0.05% atropine and prescribing DIMS lens for myopia control in …

7 - 9 years of age All Phase N/A

Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia

The objective of this clinical investigation is to evaluate the efficacy and safety of SAT-001 designed as Software as Medical Device (SaMD) for slowing myopia progression and treatment in pediatric myopia patients.

5 - 8 years of age All Phase N/A

Stellest Lenses and Low-concentration Atropine Myopia Control Among Children

The prevalence of myopia is increasing globally, especially in Asian countries. 70-80% of the young population suffers from myopia, and almost 20% have high myopia. High myopia can easily lead to blinding diseases, including retinal detachment, macular degeneration, and glaucoma. In Taiwan, according to a survey by the National Health …

6 - 12 years of age All Phase N/A
J Jen Brite

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens

This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will be used to predict the 3-year treatment efficacy. This is a randomized, controlled (1:1), multisite, subject- and observer-masked, 2-arm parallel group study.

6 - 8 years of age All Phase N/A

Assessment of DOT Spectacles in Chinese Children Extension

This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.

8 - 16 years of age All Phase N/A

Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children.

Phase III clinical study to evaluate the efficacy of Alleance® (atropine sulfate 0.01%) ophthalmic solution through the incidence of unexpected adverse events, changes in Best Corrected Visual Acuity (BCVA), changes in intraocular pressure, changes in the amplitude of accommodation, compared to placebo, as a treatment to delay the progression of …

3 - 12 years of age All Phase 3

Children's Viewing Behavior

The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.

7 - 14 years of age All Phase N/A
K Keeley Boever

Contoura With Phorcides Compared to Wavefront Optimized LASIK

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

21 - 38 years of age All Phase N/A
J Jenny QIU, MD

Software Refraction With Mobilerone Versus Retinoscopy

Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.

10 - 46 years of age All Phase N/A

Simplify language using AI